canthin-6-one has been researched along with Cancer of Prostate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergès, T; Bernard, M; Dejos, C; Régnacq, M; Voisin, P | 1 |
| Devkota, KP; Happi, EN; Moladje Donkwe, SM; Ndjakou Lenta, B; Neumann, B; Sewald, N; Stammler, HG; Wansi, JD | 1 |
2 other study(ies) available for canthin-6-one and Cancer of Prostate
| Article | Year |
|---|---|
Canthin-6-one displays antiproliferative activity and causes accumulation of cancer cells in the G2/M phase.
Topics: Animals; Apoptosis; Carbolines; Cell Cycle; DNA; Dose-Response Relationship, Drug; G2 Phase; HeLa Cells; HT29 Cells; Humans; Indole Alkaloids; Jurkat Cells; Male; Mice; NIH 3T3 Cells; Prostatic Neoplasms; Rats | 2014 |
Oxidative burst inhibitory and cytotoxic activity of constituents of the fruits of Odyendyea gabonensis.
Topics: Alkaloids; Antineoplastic Agents, Phytogenic; Carbolines; Fruit; Humans; Indole Alkaloids; Male; Molecular Structure; Phytosterols; Plant Extracts; Plant Stems; Prostatic Neoplasms; Quassins; Respiratory Burst; Simaroubaceae; Tumor Cells, Cultured | 2012 |